These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17336410)

  • 1. Extensive exfoliative dermatitis induced by non-ionic contrast medium Iodixanol (Visipaque) used during percutaneous coronary intervention.
    Choi CU; Rha SW; Suh SY; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2008 Feb; 124(2):e25-7. PubMed ID: 17336410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
    Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous late stent thrombosis of drug-eluting stents causing acute anterior and inferior myocardial infarction.
    Arora N; Aggarwal K
    J Invasive Cardiol; 2008 Jan; 20(1):E14-7. PubMed ID: 18174623
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
    Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late in-stent restenosis (five years) presenting as an ST elevation acute myocardial infarction.
    Bertrand OF; Rodés-Cabau J; Poirier P
    Can J Cardiol; 2004 Dec; 20(14):1481-3. PubMed ID: 15614345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of giant aneurysm following percutaneous coronary intervention.
    Panja M; Basu S; Mondol S
    Indian Heart J; 2005; 57(6):731-3. PubMed ID: 16521650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful non contrast percutaneous coronary intervention for patient with unstable angina and prior anaphylactic reaction to iodinated contrast medium.
    Sakakibara M; Tsutsui H
    Intern Med; 2009; 48(19):1753-7. PubMed ID: 19797832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accepted TCT challenging case: common femoral artery perforation after primary percutaneous coronary intervention successfully treated with a novel transcatheter "thrombin-blood patch" injection technique.
    Maluenda G; Waksman R; Bernardo NL
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):805-8. PubMed ID: 21061252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG; Stenport G; Andersson M
    Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unpleasant surprise in the setting of primary percutaneous coronary intervention: diffuse and severe vessel ectasia with acute thrombosis of the distal right coronary artery in a patient with acute inferior myocardial infarction.
    Milazzo D; Caramanno G; Innocente P; La Mantia R; Vaccaro I
    Ital Heart J; 2005 Apr; 6(4):353-6. PubMed ID: 15902937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of contrast-induced encephalopathy using iodixanol.
    Chisci E; Setacci F; de Donato G; Setacci C
    J Endovasc Ther; 2011 Aug; 18(4):540-4. PubMed ID: 21861745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; You SJ; Wu YJ; Gao RL
    Int J Cardiol; 2008 Jun; 126(3):435-6. PubMed ID: 17462753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug.
    Ozturk U; Sungur MA; Karakas T; Mulayim K; Ozturk P
    Cutan Ocul Toxicol; 2015; 34(4):344-6. PubMed ID: 25363067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.